Armata Total Current Liabilities from 2010 to 2024
ARMP Stock | USD 4.10 0.06 1.49% |
Total Current Liabilities | First Reported 1993-12-31 | Previous Quarter 21.9 M | Current Value 16.5 M | Quarterly Volatility 7.5 M |
Check Armata Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Armata main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 2.8 M or Selling General Administrative of 11.1 M, as well as many exotic indicators such as Price To Sales Ratio of 24.52, Dividend Yield of 0.0175 or Operating Cycle of 137. Armata financial statements analysis is a perfect complement when working with Armata Pharmaceuticals Valuation or Volatility modules.
Armata | Total Current Liabilities |
Latest Armata Pharmaceuticals' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Armata Pharmaceuticals over the last few years. Total Current Liabilities is an item on Armata Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Armata Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Armata Pharmaceuticals' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Armata Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
Timeline |
Armata Total Current Liabilities Regression Statistics
Arithmetic Mean | 6,533,070 | |
Geometric Mean | 4,105,768 | |
Coefficient Of Variation | 109.53 | |
Mean Deviation | 5,225,436 | |
Median | 3,580,000 | |
Standard Deviation | 7,155,790 | |
Sample Variance | 51.2T | |
Range | 24M | |
R-Value | 0.73 | |
Mean Square Error | 25.6T | |
R-Squared | 0.53 | |
Significance | 0 | |
Slope | 1,170,244 | |
Total Sum of Squares | 716.9T |
Armata Total Current Liabilities History
About Armata Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Armata Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Armata Pharmaceuticals investors use historical funamental indicators, such as Armata Pharmaceuticals's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Armata Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Armata Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Armata Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Armata Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Armata Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Total Current Liabilities | 16.5 M | 17.3 M |
Pair Trading with Armata Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Armata Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Armata Stock
0.55 | CVS | CVS Health Corp Financial Report 1st of May 2024 | PairCorr |
0.51 | MEIP | MEI Pharma Financial Report 9th of May 2024 | PairCorr |
0.48 | MDXG | MiMedx Group Sell-off Trend | PairCorr |
0.46 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.46 | CALT | Calliditas Therapeutics Financial Report 21st of May 2024 | PairCorr |
The ability to find closely correlated positions to Armata Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Armata Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Armata Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Armata Pharmaceuticals to buy it.
The correlation of Armata Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Armata Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Armata Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Armata Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Armata Pharmaceuticals Correlation against competitors. To learn how to invest in Armata Stock, please use our How to Invest in Armata Pharmaceuticals guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Armata Stock analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Armata Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Armata Pharmaceuticals. If investors know Armata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Armata Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 0.126 | Quarterly Revenue Growth 0.454 | Return On Assets (0.26) | Return On Equity (34.39) |
The market value of Armata Pharmaceuticals is measured differently than its book value, which is the value of Armata that is recorded on the company's balance sheet. Investors also form their own opinion of Armata Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Armata Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Armata Pharmaceuticals' market value can be influenced by many factors that don't directly affect Armata Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Armata Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Armata Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Armata Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.